Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib in Relapsed/Refractory Ph+ ALL Chinese Adults
CTR20132714Phase 4Suspended
- Sponsor
- Novartis
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of imatinib in acute lymphoblastic leukemia (ALL), sponsored by Novartis. Started Sep 2014; status: suspended.
02
Drugs
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on CTR20132714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132714.